Graft Versus Host Disease

Links shared publicly online about this topic

Graft-Versus-Host Disease - New Graft-Versus-Host Disease Study Findings Hav...

newsrx.com — “NewsRx is the leading source of news and information on Graft-Versus-Host DiseaseView full resource at newsrx.com

  • View Related
  • Share

Most Recently Shared on July 19, 2011 at 1:00 pm By:

NewsRx NewsRx Medical News Health News

New Graft-Versus-Host Disease Study Findings Have Been Reported by Scientists at...http://bit.ly/rcxQUP

10 months ago...

Breast Augmentation and Graft versus Host Disease ~ Can Graft Versus Host Disease Complicated Breast Augmentation Surgery?

realself.com — “Answer from Glenn Vallecillos, MD: Thanks for the question. While a breast implant is in theory "inert" and shouldn't elicit an atypical...View full resource at realself.com

  • View Related
  • Share

Most Recently Shared on January 20, 2011 at 6:00 am By:

Protecting Gut Stem Cells To Prevent Graft-Versus-Host Disease

medicalnewstoday.com — “A protein that protects stem cells in the gut relieves a potentially lethal complication of bone marrow transplantation in mice, according to a study published online on January 31 in the JourView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on February 1, 2011 at 4:05 pm By:

mnt_leukemia MNT Leukemia Health News

Protecting Gut Stem Cells To Prevent Graft-Versus-Host Disease http://mnt.to/3QG6 #lymphoma #leukemia

1 year ago...

Blood test could improve graft-versus-host disease treatment

sciencedaily.com — “Researchers have identified the first biomarker of graft-versus-host disease of the skin. The discovery makes possible a simple blood test that should solve a treatment dilemma facing doctors with patients who frequently develop rashes after bone marrow transplants.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on January 8, 2010 at 3:07 pm By:

medical_tweets medical_tweets Health News

Blood test could improve graft-versus-host disease treatment Researchers have identified the first biomarker of graft.. http://bit.ly/92YgM6

2 years ago...

Blood test could improve graft-versus-host disease treatment

feeds.sciencedaily.com — “Researchers have identified the first biomarker of graft-versus-host disease of the skin. The discovery makes possible a simple blood test that should solve a treatment dilemma facing doctors with patients who frequently develop rashes after bone marrow transplants.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on January 8, 2010 at 3:07 pm By:

sciencedaily sciencedaily Health News

Blood test could improve graft-versus-host disease treatment: Researchers have identified the first biomarker of g... http://bit.ly/7bgPDB

2 years ago...

Treatment May Limit Graft-Versus-Host Disease - Drugs.com MedNews

drugs.com — “By being treated with anti-T-cell globulin, a new study has shown. from the bone marrow or peripheral blood of unrelated donors. In GVHD, the immune system or TView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 10:10 pm By:

drugscom Drugs.com Health Site

Treatment May Limit Graft-Versus-Host Disease - http://bit.ly/oi73g

3 years ago...

Regulatory T-Cell Clue May Help Prevent Graft-Versus-Host Disease

medicalnewstoday.com — “Graft-versus-host disease (GVHD) is a serious risk in many kinds of cell transplants, including for stem cell transplants carried out when stem cells are partially depleted of conventional T cellsView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 2, 2011 at 8:05 am By:

mnt_stemcell MNT Stem Cell News Health News

Regulatory T-Cell Clue May Help Prevent Graft-Versus-Host Disease http://t.co/lDEOo1eF #stemcell

7 months ago...

Potential New Approach For Treating Graft-Versus-Host-Disease Provided By Natural Enzyme

medicalnewstoday.com — “A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 19, 2012 at 8:05 am By:

mnt_vaccines MNT Vaccines Health News

Potential New Approach For Treating Graft-Versus-Host-Disease Provided By Natural Enzyme http://t.co/27v7eSyA #vaccines #immunesystem

4 months ago...

Compound Selectively Silences Pathogenic Cells And Arrests Graft-Versus-Host Disease

medicalnewstoday.com — “Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, has announced positive data from the University oView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 28, 2011 at 1:05 pm By:

mnt_vaccines MNT Vaccines Health News

Compound Selectively Silences Pathogenic Cells And Arrests Graft-Versus-Host Disease http://mnt.to/3Qxt #vaccines #immunesystem

1 year ago...

Chronic graft-versus-host disease may remain stable after hematopoietic cell transplantation

osnsupersite.com — “A small population of patients with chronic graft-versus-host disease demonstrated stable visual acuity, tear production and lissamine green staView full resource at osnsupersite.com

  • View Related
  • Share

Most Recently Shared on February 18, 2011 at 4:44 pm By:

OSNSuperSite The OSN SuperSite Health News

Chronic graft-versus-host disease may remain stable after hematopoietic #cell #transplantation: http://ht.ly/3Z7bJ

1 year ago...

Early infusion of donor T cells prevents graft versus host disease in blood cancer patients, study suggests

sciencedaily.com — “Scientists have developed a potential new strategy for preventing graft-versus-host disease and promoting the patient's immune system recovery after hematopoietic stem cell transplantation.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 7:07 pm By:

sciencedaily sciencedaily Health News

Early infusion of donor T cells prevents graft versus host disease in blood cancer patients, study suggests: Sci... http://bit.ly/gtOnFS

1 year ago...

Early infusion of donor T cells prevents graft versus host disease in blood cancer patients

physorg.com — “For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 6:26 pm By:

FightCancer FightCancer Health News

Early infusion of donor T cells prevents graft versus host disease in blood cancer patients http://bit.ly/gHa0Pr

1 year ago...

Immunosuppression and breast implant augmentation surgery ~ Can Graft Versus Host Disease Complicated Breast Augmentation Surgery?

realself.com — “Steroids are immunosuppressants and may effect immunomodulators which can result in an increased risk of wound healing problems and infection.View full resource at realself.com

  • View Related
  • Share

Most Recently Shared on January 21, 2011 at 5:37 am By:

Cholesterol-lowering drugs also may protect stem cell transplant patients from graft-versus-host disease

feeds.sciencedaily.com — “Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the US. Now a new study indicates that statins may protect stem cell transplant patients from one of the most serious complications of the life-saving cancer therapy: graft-versus-host disease, or GVHD.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on December 4, 2009 at 8:09 pm By:

sciencedaily sciencedaily Health News

Cholesterol-lowering drugs also may protect stem cell transplant patients from graft-versus-host disease: Cholester... http://bit.ly/4ywKPa

2 years ago...

Safety and Efficacy of the mTOR Inhibitor Everolimus As Early Interventional Replacement for Calcineurin Inhibitors (CNI) in Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation - ONA

oncologynurseadvisor.com — “The use of everolimus, a mammalian target of rapamycin (mTOR) inhibitor, is feasible and efficacious for the prevention of graft-versus-host disease (GVHD) in a series of patients after allogeneic stem cell transplantation (SCT), according to a study presented at the 52nd American Society of Hematology Meeting and Exposition..View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 3:23 pm By:

ONAcom OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher

Safety and Efficacy of the mTOR Inhibitor Everolimus As Early Interventional Replacement for… http://goo.gl/fb/mut9f

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390